Evaluating the impact of growth differentiation factor 15 on the risk of psoriasis

Int J Rheum Dis. 2024 Aug;27(8):e15316. doi: 10.1111/1756-185X.15316.

Authors

Yuqing Jiang¹, Jiayu Li¹, Baojie Hua¹, Yudan Yang¹, Ying Chen¹, Wei Liu¹, Xiaohui Sun¹, Ding Ye¹, Zhixing He², Yingying Mao¹

Affiliations

¹ Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, China.
² Key laboratory of Rheumatology of Zhejiang Province, School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.

PMID: 39180311
DOI: 10.1111/1756-185X.15316

No abstract available

Publication types

Letter

MeSH terms

Adult
Biomarkers / blood
Case-Control Studies
Female
Growth Differentiation Factor 15* / blood
Humans
Male
Middle Aged
Psoriasis* / diagnosis
Risk Assessment
Risk Factors

Substances

Growth Differentiation Factor 15
GDF15 protein, human
Biomarkers

Grants and funding